In this study, we investigated whether ursodeoxycholic acid (UDCA), a widely used bile acid sequestrant used therapeutically in liver diseases, induces GLP-1 secretion, and assessed its effects on glucose and insulin levels in healthy subjects. The gene discussed is GCG; the disease is liver disorder.